US Pharma MarketingBig Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma.
Source: FierceBiotech